InsiderTrades

Rubin Steven D

SEC CIK 1381874 · EDGAR

Buying vs selling by month open-market trades, last 41 months, all 6 companies
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
ENTXEntera Bio Ltd.Dir 34.1K $19.4K — 32026-02-092026-08-07
OPKOPKO HEALTH, INC.Executive VP-Administration, Dir 6.57M $21.7K — 42023-11-102026-07-24
RDVTRed Violet, Inc.Dir 147.8K — $389.3K 72021-09-242026-06-04
ELOXEloxx Pharmaceuticals, Inc.Dir 14.6K — — 32024-10-162026-01-24
COCPCocrystal Pharma, Inc.Dir 2.66M — — 12024-10-092024-10-09
NAGENiagen Bioscience, Inc.Dir 7,000 $10.2K — 12023-05-252023-05-25

Most active insiders at ENTX, 12 months

#InsiderTitleBoughtSold
1 Germano Geno JDir $55.8K—
2 Ellis SeanDir $34.6K—
3 Toledano Miranda JayneCEO, Dir $19.9K—
4 Rubin Steven DDir $19.4K—
5 Taitel HayaDir $11.1K—
6 Burshtein GregoryChief of R, D ——
7 Yaacov-Garbeli DanaCFO ——
8 Malca YonatanDir ——
9 Galitzer HillelCOO ——
10 OSTROV GERALD MDir ——

Transactions 19

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
D 2026-08-07 16:23 2026-08-07 ENTX Entera Bio Ltd. Rubin Steven D Dir A - Grant $0.00 +19.1K 34.1K +127% $0
2026-07-28 16:21 2026-07-24 OPK OPKO HEALTH, INC. Rubin Steven D Executive VP-Administration, Dir F - Tax $1.22 -53.3K 6.57M -0.8% -$65.0K
2026-06-05 16:57 2026-06-04 RDVT Red Violet, Inc. Rubin Steven D Dir A - Grant — +2,179 147.8K +1% —
D 2026-05-08 17:12 2026-01-24 ELOX Eloxx Pharmaceuticals, Inc. Rubin Steven D Dir M - OptEx — +1,875 14.6K +15% —
2026-02-17 2026-02-12 ENTX Entera Bio Ltd. Rubin Steven D Dir P - Purchase $1.49 +5,000 15.0K +50% +$7,450
2026-02-11 2026-02-09 ENTX Entera Bio Ltd. Rubin Steven D Dir P - Purchase $1.20 +10.0K 10.0K New +$12.0K
2025-12-22 2025-12-19 RDVT Red Violet, Inc. Rubin Steven D Dir A - Grant — +4,450 145.6K +3% —
2025-03-21 2025-03-19 RDVT Red Violet, Inc. Rubin Steven D Dir S - Sale $38.93 -10.0K 141.1K -7% -$389.3K
D 2025-01-28 2025-01-24 ELOX Eloxx Pharmaceuticals, Inc. Rubin Steven D Dir M - OptEx $0.00 +3,750 15.8K +31% $0
2024-11-05 2024-11-04 RDVT Red Violet, Inc. Rubin Steven D Dir A - Grant — +8,000 151.1K +6% —
2024-10-17 2024-10-16 ELOX Eloxx Pharmaceuticals, Inc. Rubin Steven D Dir A - Grant $0.00 +12.0K 12.0K New $0
2024-10-11 2024-10-09 COCP Cocrystal Pharma, Inc. Rubin Steven D Dir A - Grant — +19.0K 2.66M +0.7% —
2024-07-26 2024-07-24 OPK OPKO HEALTH, INC. Rubin Steven D Executive VP-Administration, Dir A - Grant $0.00 +437.5K 6.63M +7% $0
2024-01-05 2024-01-05 OPK OPKO HEALTH, INC. Rubin Steven D Executive VP-Administration, Dir P - Purchase $0.87 +10.0K 6.19M +0.2% +$8,700
2023-12-04 2023-11-30 RDVT Red Violet, Inc. Rubin Steven D Dir A - Grant — +10.8K 143.1K +8% —
2023-11-13 2023-11-10 OPK OPKO HEALTH, INC. Rubin Steven D Executive VP-Administration, Dir P - Purchase $1.30 +10.0K 6.18M +0.2% +$13.0K
2023-05-30 2023-05-25 NAGE Niagen Bioscience, Inc. Rubin Steven D Dir P - Purchase $1.46 +7,000 7,000 New +$10.2K
2022-10-13 2022-10-12 RDVT Red Violet, Inc. Rubin Steven D Dir A - Grant — +10.8K 132.3K +9% —
2021-09-27 2021-09-24 RDVT Red Violet, Inc. Rubin Steven D Dir A - Grant — +8,900 121.5K +8% —

Purchase Sale Sale after option exercise All abbreviations